Retrieval of individual patient data depended on study characteristics: a randomized controlled trial

被引:21
|
作者
Veroniki, Areti Angeliki [1 ,2 ,3 ]
Ashoor, Huda M. [2 ]
Le, Susan P. C. [2 ]
Rios, Patricia [2 ]
Stewart, Lesley A. [4 ]
Clarke, Mike [5 ]
Mavridis, Dimitris [1 ,6 ]
Straus, Sharon E. [2 ,7 ]
Tricco, Andrea C. [2 ,8 ]
机构
[1] Univ Ioannina, Sch Educ, Dept Primary Educ, Ioannina, Greece
[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada
[3] Imperial Coll, Fac Med, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England
[4] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England
[5] Queens Univ Belfast, Northern Ireland Hub Trials Methodol Res, Ctr Publ Hlth, Belfast, Antrim, North Ireland
[6] Paris Descartes Univ, Sorbonne Paris Cite, Fac Med, Paris, France
[7] Univ Toronto, Dept Geriatr Med, Toronto, ON, Canada
[8] Univ Toronto, Dalla Lana Sch Publ Hlth, Epidemiol Div, Toronto, ON, Canada
基金
欧盟地平线“2020”; 加拿大健康研究院;
关键词
Meta-analysis; Patient-level data; Individual participant data; Incentive; Data retrieval; Data sharing; PARTICIPANT DATA METAANALYSES; IPD; DECLARATION; SCIENCE; LEVEL;
D O I
10.1016/j.jclinepi.2019.05.031
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The aim of the study was to examine the effect of providing a financial incentive to authors of randomized clinical trials (RCTs) to obtain individual patient data (IPD). Study Design and Setting: Parallel-group RCT with authors identified in the RCTs eligible for two systematic reviews. The authors were randomly allocated to the intervention (financial incentive with several contact approaches) or control group (using the same contact approaches). Studied outcomes are proportion of authors who provided IPD, time to obtain IPD, and completeness of IPD received. Results: Of the 129 authors contacted, 37 authors suggested or contacted a person or funder providing relevant details or showed interest to collaborate, whereas 45 authors directed us to contact a person or funder, lacked resources or time, did not have ownership or approval to share the IPD, or claimed IPD was too old. None of the authors shared their IPD. We contacted 17 sponsors and received two complete IPD datasets from one sponsor. The time to obtain IPD was >1 year after a sponsor's positive response. Common barriers included study identification, data ownership, limited data access, and required IPD licenses. Conclusion: IPD sharing may depend on study characteristics, including funding type, study size, study risk of bias, and treatment effect, but not on providing a financial incentive. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:176 / 188
页数:13
相关论文
共 50 条
  • [41] Patient navigation and clinical trial participation: A randomized controlled trial design
    Uveges, Melissa Kurtz
    Lansey, Dina George
    Mbah, Olive
    Gray, Tamryn
    Sherden, Lisa
    Wenzel, Jennifer
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 12 : 98 - 102
  • [42] Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial
    Boadie W Dunlop
    Elisabeth B Binder
    Joseph F Cubells
    Mark M Goodman
    Mary E Kelley
    Becky Kinkead
    Michael Kutner
    Charles B Nemeroff
    D Jeffrey Newport
    Michael J Owens
    Thaddeus W W Pace
    James C Ritchie
    Vivianne Aponte Rivera
    Drew Westen
    W Edward Craighead
    Helen S Mayberg
    Trials, 13
  • [43] Chimney Trial: study protocol for a randomized controlled trial
    Elisa Mäkäräinen-Uhlbäck
    Heikki Wiik
    Jyrki Kössi
    Maziar Nikberg
    Pasi Ohtonen
    Tero Rautio
    Trials, 20
  • [44] Chimney Trial: study protocol for a randomized controlled trial
    Makarainen-Uhlback, Elisa
    Wiik, Heikki
    Kossi, Jyrki
    Nikberg, Maziar
    Ohtonen, Pasi
    Rautio, Tero
    TRIALS, 2019, 20 (01)
  • [45] PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY
    Perkovic, Vlado
    Barratt, Jonathan
    Carroll, Kevin
    Fajardo, Cecile
    Hafkin, Jeffrey
    Lafayette, Richard
    Liew, Adrian
    Shah, Lokesh
    Suzuki, Yusuke
    Tesar, Vladimir
    Trimarchi, Hernan
    Wong, Muh Geot
    Xia, Jing
    Zhan, Hong
    Rizk, Dana, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [46] Preloop trial: study protocol for a randomized controlled trial
    Elisa Mäkäräinen-Uhlbäck
    Heikki Wiik
    Jyrki Kössi
    Pasi Ohtonen
    Tero Rautio
    Trials, 19
  • [47] Preloop trial: study protocol for a randomized controlled trial
    Makarainen-Uhlback, Elisa
    Wiik, Heikki
    Kossi, Jyrki
    Ohtonen, Pasi
    Rautio, Tero
    TRIALS, 2018, 19
  • [48] Cluster randomized, controlled trial on patient safety improvement in general practice: a study protocol
    Natasha J Verbakel
    Maaike Langelaan
    Theo JM Verheij
    Cordula Wagner
    Dorien LM Zwart
    BMC Family Practice, 14
  • [49] A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial
    Vigod, Simone
    Hussain-Shamsy, Neesha
    Grigoriadis, Sophie
    Howard, Louise M.
    Metcalfe, Kelly
    Oberlander, Tim F.
    Schram, Carrie
    Stewart, Donna E.
    Taylor, Valerie H.
    Dennis, Cindy-Lee
    TRIALS, 2016, 17
  • [50] Cluster randomized, controlled trial on patient safety improvement in general practice: a study protocol
    Verbakel, Natasha J.
    Langelaan, Maaike
    Verheij, Theo J. M.
    Wagner, Cordula
    Zwart, Dorien L. M.
    BMC FAMILY PRACTICE, 2013, 14